Avacta Group plc (AVCT) Ordinary Shares 10p
1.30p
(3.13%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.30p
(3.13%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1.30p
(3.13%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
41.00p
42.35p
82.50p
£150.12 million
41.50p
40.00p
31.25p
n/a
1.10p (2.58%) Previous:
1.10p
803,322
n/a
20,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | 23.25 | 9.65 |
| Profit before tax (£m) | (27.32) | (41.64) |
| Adjusted EPS (p): | (9.15) | (14.48) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Avacta agrees to sell UK-based diagnostics unit
7 March 2025 09:26
-
Avacta reports promising results from ongoing clinical trial
16 January 2025 07:23
-
Peel Hunt starts Avacta at 'buy' with 99p price target
21 November 2024 15:22
-
Avacta to Present at Leerink Healthcare Conference
10 March 2025 07:00
-
Avacta announces data update for AVA6000
7 March 2025 08:40
-
Avacta to sell Launch Diagnostics
7 March 2025 07:42
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.